The inhibition by bacitracin of the en- Bacitracin is an antibiotic produced by strains of Bacillus licheniformis. It is a mixture of closely related compounds, the main component of which (bacitracin A) is a cyclic polypeptide with a peptide side chain ( Fig. 1) (1-3). An unusual feature of the structure is the occurrence of a thiazoline ring formed between the L-cysteine and L-isoleucine residues at the N-terminal end of the acylic peptide side-chain. The free amino group of iisoleucine at the N-terminal end is adjacent to the thiazoline ring and is essential for antimicrobial activity. The transformation of bacitracin A to bacitracin F (in which the amino group is replaced by a carbonyl group) results in total loss of antimicrobial activity. A metal ion may be essential for the antimicrobial activity of bacitracin (4-1 1). The antimicrobial activity is stimulated by various metal ions and inhibited by metal-chelating agents, such as EDTA. Spectroscopic evidence for the interaction of bacitracin with metal ions has been obtained. The chelation may involve both the nitrogen of the thiazoline ring and the adjacent free amino-group in isoleucine; this chelation could assist in stabilizing the thiazoline ring, thus hindering the deamination to bacitracin F (10). It has been further postulated that in the zinc-bacitracin A complex, the zinc also coordinates through the imidazole of the histidine residue and the peptide nitrogen of the histidine residue, thus forming a oneto-one complex with bacitracin (10).Various biochemical lesions induced by bacitracin have been reported (9). Several effects, such as inhibition of induced enzyme synthesis and stimulation of efflux of K+ ions, could be ascribed to alterations in cell-membrane function. The antibiotic also inhibits incorporation of ['4C]aminoacids into cell walls and induces the accumulation of uridine-nucleotide precursors of the wall under conditions in which incorporation of amino acids into protein is unaffected (12-15). However, since bacitracin affects protoplasts of bacteria, its action is not limited to effects on cell walls. The precise site of action in cell wall synthesis has been defined as inhibition of the dephosphorylation of C55-isoprenyl pyrophosphate. This reaction is essential for regeneration of the lipid carrier required for the cyclic synthesis of peptidoglycan (16, 17). In the present paper, data are presented which suggest that bacitracin acts by forming a complex with C55-isoprenyl pyrophosphate (a component of the cell membrane) and divalent cations. The metal ion may serve as a bridge between the antibiotic and the substrate.
MATERIALS AND METHODSThe C55-isoprenyl pyrophosphatase used was that present in membranes of Streptococcus fecalis. The membranes were prepared and washed with EDTA and 2 M LiCl as described previously (through step 2 of the procedure) (Staudenbauer, W. L., and J. L., Strominger, J. Biol. Chem., submitted). The residual LiCl was removed by washing with water and then dialysis against water. Finally, the memb...